ADC Therapeutics (ADC Therapeutics) Days Payable : 543.21 (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is ADC Therapeutics Days Payable?

ADC Therapeutics's average Accounts Payable for the three months ended in Mar. 2024 was $14.94 Mil. ADC Therapeutics's Cost of Goods Sold for the three months ended in Mar. 2024 was $2.51 Mil. Hence, ADC Therapeutics's Days Payable for the three months ended in Mar. 2024 was 543.21.

The historical rank and industry rank for ADC Therapeutics's Days Payable or its related term are showing as below:

ADCT' s Days Payable Range Over the Past 10 Years
Min: 972.12 Med: 2014.79 Max: 2274.24
Current: 972.12

During the past 8 years, ADC Therapeutics's highest Days Payable was 2274.24. The lowest was 972.12. And the median was 2014.79.

ADCT's Days Payable is ranked better than
84.81% of 724 companies
in the Biotechnology industry
Industry Median: 148.12 vs ADCT: 972.12

ADC Therapeutics's Days Payable increased from Mar. 2023 (0.00) to Mar. 2024 (543.21). It may suggest that ADC Therapeutics delayed paying its suppliers.

ADC Therapeutics Days Payable Historical Data

The historical data trend for ADC Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ADC Therapeutics Days Payable Chart

ADC Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

2,274.24

1,350.70

2,014.79

ADC Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															-	705.13	2,576.44	4,409.10	543.21

Competitive Comparison of ADC Therapeutics's Days Payable

For the Biotechnology subindustry, ADC Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ADC Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ADC Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where ADC Therapeutics's Days Payable falls into.

ADC Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

ADC Therapeutics's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (12.351	+	15.569)	/	2 )	/	2.529	*	365
=	13.96					/	2.529	*	365
=	2,014.79

ADC Therapeutics's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (15.569	+	14.315)	/	2 )	/	2.51	*	365 / 4
=	14.942					/	2.51	*	365 / 4
=	543.21

ADC Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of ADC Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

ADC Therapeutics (ADC Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ADC Therapeutics SA (NYSE:ADCT) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Route de la Corniche 3B, Biopole, Epalinges, CHE, 1066

Website

https://www.adctherapeutics.com

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.